Teva Pharmaceutical Industries Limited (TEVA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Teva Pharmaceutical Industries Limited  (NYSE: TEVA)


Teva Pharmaceutical Industries Limited's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Teva Pharmaceutical Industries Limited's ROI in the second quarter of 2026?
Teva Pharmaceutical Industries Limited achieved a return on average invested assets (ROI) of 2.66 % in its second quarter of 2026, this is above TEVA's average return on investment of -0.41%.
Teva Pharmaceutical Industries Limiteds investments during the 12 months ending in the second quarter of 2026 are valued at $26 billion

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 158 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 1413, from total ROI ranking in the first quarter of 2026 at 1746.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -4.64 % -0.57 % -1.57 % -5.34 % -7.81 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 24,215 26,879 26,680 28,760 28,694
Return On Investment (TTM) 2.66 % 5.65 % 5.08 % 2.36 % -0.58 %
TEVA's Overall Ranking # 1413 # 1746 # 1985 # 2632 # 2956
Seq. Investment Change TTM -4.03 % -0.61 % -0.31 % 0.3 % 0.06 %
Seq. Net Income Change TTM -54.75 % 10.51 % 114.52 % - -
Net Income (TTM) in Millions 709 1,567 1,418 661 -163

TEVA Company Profile >> Back to TEVA Roi Comparisons >> See Annual TEVA Return On Investment



Return On Investment TEVA's Ranking
Within: No.
Industry # 56
Sector # 159
Overall # 1413

Return On Investment Statistics
High Average Low
13.28 %
-0.41 %
-38.06 %
(Dec 31 2010)   (Dec 31 2017)







Financial Statements
Teva Pharmaceutical Industries Limited's II. Quarter Investments $ 24,215 Millions TEVA's Balance sheet
Teva Pharmaceutical Industries Limited's II. Quarter Income $ -575 Millions Quarterly TEVA's Income Statement
TEVA's Income by Division See TEVA's Income by Division


TEVA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 27,987 27,031 32,540 33,905 38,547
Y / Y Investment Growth 3.54 % -16.93 % -4.03 % -12.04 % -2.65 %
Net Income in Millions 1,418 -1,959 -615 -2,499 456
Y / Y Net Income Growth - - - - -
Annual Return On Investment 5.07 % -7.25 % -1.89 % -7.37 % 1.18 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 5.07 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TEVA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TEVA's Competitors
Subscribers only: Roi for Teva Pharmaceutical Industries Limited's Suppliers
Subscribers only: Return On Investment for TEVA's Customers

Other Ratios
TEVA's Roa TEVA's Inventory Turnover Ratio TEVA's Growth Rates TEVA's Dividend Statistics
TEVA's Profitability Ratios TEVA's Asset Turnover Ratio TEVA's Dividend Growth
TEVA's Roe TEVA's Valuation Ratios TEVA's Financial Strength Ratios TEVA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Davita Inc   6.92 %
Kewaunee Scientific Corporation  6.58 %
Medtronic Plc  6.46 %
Siga Technologies Inc  6.45 %
Labcorp Holdings Inc   6.11 %
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %

Date modified: 2026-08-12T20:54:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.